recurrent pheochromocytoma
Showing 1 - 25 of 7,814
Pheochromocytoma, Paraganglioma Trial in New York (Axitinib)
Recruiting
- Pheochromocytoma
- Paraganglioma
-
New York, New YorkColumbia University Irving Medical Center
Oct 5, 2022
Paraganglioma, Pheochromocytoma Trial in Canada, Netherlands (Sunitinib)
Active, not recruiting
- Paraganglioma
- Pheochromocytoma
-
Calgary, Alberta, Canada
- +3 more
Nov 29, 2021
Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States
Recruiting
- Malignant Solid Neoplasm
- +40 more
- Biospecimen Collection
- +6 more
-
Birmingham, Alabama
- +172 more
Jan 27, 2023
Dysglycemia in Pheochromocytoma and Paraganglioma
Active, not recruiting
- Pheochromocytoma
- Paraganglioma
- Catecholamines
-
Beijing, Beijing, ChinaXian-Liang Zhou
Jul 9, 2022
Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)
Completed
- Recurrent Neuroendocrine Tumor
- Metastatic Neuroendocrine Tumor
-
Cleveland, OhioCleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
Dec 1, 2022
Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute
Recruiting
- Astrocytoma, Grades II, III and IV
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Intraoperative Hemodynamic Instability During Unilateral
Recruiting
- Pheochromocytoma
- Non-Secretory Adrenal Adenoma
- adrenalectomy
-
Nancy, FranceCHRU Nancy - Département Chirurgie Viscérale, Métabolique et Can
Sep 25, 2023
Pheochromocytoma Trial in Seoul (dexmedetomidine, 0.9% normal saline)
Completed
- Pheochromocytoma
- dexmedetomidine
- 0.9% normal saline
-
Seoul, Korea, Republic ofSeverance hospital
Sep 12, 2023
Adrenal Pheochromocytoma, Hemodynamic Trial (Abandonment of intravenous volume expansion during preoperative preparation in
Completed
- Adrenal Pheochromocytoma
- Hemodynamic
- Abandonment of intravenous volume expansion during preoperative preparation in patients with pheochromocytoma
- (no location specified)
Mar 25, 2023
Neuroblastoma, Childhood Metastatic Pheochromocytoma Trial in Philadelphia (131 I-Metaiodobenzylguanidine (131 I-MIBG), 131
Available
- Neuroblastoma
- Childhood Metastatic Pheochromocytoma
- 131 I-Metaiodobenzylguanidine (131 I-MIBG)
- 131 I-MIBG
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Jul 11, 2022
Pheochromocytoma, Endocrine Disease, Endocrine Diseases Trial run by the Eunice Kennedy Shriver National Institute of Child
Recruiting
- Pheochromocytoma
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
I Hemodynamic Instability and Conversion in Adrenalectomy for
Completed
- adrenalDisease
- laparoscopic adrenalectomy
- (no location specified)
Sep 26, 2023
Anlotinib Treatment Response Using Contrast Enhanced Ultrasound
Recruiting
- Pheochromocytoma, Metastatic
- +3 more
- Contrast-enhanced ultrasound(CEUS)
-
Beijing, ChinaPeking Union Medical College Hospital
Aug 28, 2023
Pheochromocytoma, Paraganglioma Trial in Beijing (Anlotinib HCl)
Recruiting
- Pheochromocytoma
- Paraganglioma
- Anlotinib hydrochloride
-
Beijing, ChinaPeking Union Medical College Hospital
May 22, 2023
Pheochromocytoma, Paraganglioma, Inherited Cancer Syndrome Trial in San Antonio (Genetic screening)
Recruiting
- Pheochromocytoma
- +7 more
- Genetic screening
-
San Antonio, TexasUniversity of Texas Health Science Center
Aug 25, 2022
Pheochromocytoma, Paraganglioma Trial in Beijing (Temozolomide)
Recruiting
- Pheochromocytoma
- Paraganglioma
-
Beijing, ChinaPeking Union Medical College Hospital
May 22, 2023
Genetic Factors and Pheochromocytomas in Neoplasia Type 2
Recruiting
- Neoplasia
- Pheochromocytoma
-
Marseille, FranceAPHM - Hôpital de la Conception
Jan 30, 2022
Pheochromocytoma, Metastatic, Pheochromocytoma Malignant, Paraganglioma, Malignant Trial in Beijing (Penpulimab)
Recruiting
- Pheochromocytoma, Metastatic
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
May 31, 2023
Pheochromocytoma, Paraganglioma Trial in Philadelphia ([18F]FluorThanatrace ([18F]FTT))
Not yet recruiting
- Pheochromocytoma
- Paraganglioma
- [18F]FluorThanatrace ([18F]FTT)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Dec 1, 2022
Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in Rochester
Completed
- Malignant Adrenal Gland Pheochromocytoma
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Sep 28, 2022
Pheochromocytoma, Metastatic, Paraganglioma, Malignant, Pheochromocytoma Malignant Trial in Beijing (Temozolomide capsule)
Completed
- Pheochromocytoma, Metastatic
- +2 more
- Temozolomide capsule
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 4, 2023
Advanced Adrenal Gland Pheochromocytoma, Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in United
Recruiting
- Advanced Adrenal Gland Pheochromocytoma
- +5 more
- Olaparib
- +2 more
-
Anchorage, Alaska
- +153 more
Aug 23, 2022
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease Trial in Worldwide (Belzutifan)
Recruiting
- Pheochromocytoma/Paraganglioma
- +2 more
-
Los Angeles, California
- +58 more
Jan 27, 2023
Magnesium and Dexmedetomidine in Pheochromocytoma
Completed
- Phaeochromocytoma Crisis
- Hemodynamic Instability
- (no location specified)
Oct 20, 2021